van Haften, Floortje J. https://orcid.org/0000-0003-4089-7142
van der Sluis, Tetje C. https://orcid.org/0000-0003-1804-1647
Hepp, Hanna S. https://orcid.org/0009-0009-5126-5731
Mülling, Nils https://orcid.org/0000-0002-3534-233X
Nadafi, Reza
Sampadi, Bharath
van Duikeren, Suzanne https://orcid.org/0000-0001-7391-5832
Mostert, J. Shirin https://orcid.org/0009-0000-2993-8455
van der Sterre, Rosemarijn
van Veelen, Peter A. https://orcid.org/0000-0002-7898-9408
Heieis, Graham A.
Veerkamp, Dominique M. B.
Wesselink, Thomas H.
Vleeshouwers, Ward https://orcid.org/0000-0003-1264-3559
Beijnes, Macha
Pardieck, Iris N.
van Horssen, Eralin L. F. https://orcid.org/0009-0009-8700-076X
de Groot, Anne F.
van der Ploeg, Manon
Kroep, Judith R.
de Miranda, Noel F. C. C. https://orcid.org/0000-0001-6122-1024
van der Zanden, Sabina Y. https://orcid.org/0000-0001-5587-1514
Neefjes, Jacques https://orcid.org/0000-0001-6763-2211
Mei, Hailiang https://orcid.org/0000-0003-1781-5508
Vertegaal, Alfred C. O.
Everts, Bart https://orcid.org/0000-0002-3764-5131
van der Burg, Sjoerd H. https://orcid.org/0000-0002-6556-0354
Arens, Ramon https://orcid.org/0000-0001-5058-4110
Funding for this research was provided by:
KWF Kankerbestrijding (11750)
Leids Universitair Medisch Centrum (Gisela Thier)
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (Vici 724016003)
Article History
Received: 22 August 2024
Accepted: 12 December 2025
First Online: 19 January 2026
Competing interests
: This study has been conducted by LUMC, which holds a patent on the use of T cell cycle synchronization to optimize antitumor responses (No2019548). T.C.S., S.H.B. and R.A. are named inventors on this patent. The other authors declare no competing interests.